Engineers fix problems with today's lab-on-a-chip devices by protecting crucial blood cells from electrical damage.
A new method using advanced microfluidics and miscroscopy could offer clinicians a better way of detecting blood clots to prevent strokes and heart attacks.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
A new device from scientists at McGill University’s Department of Bioengineering allows early and quick detection of life-threatening bacteria.
A new process of running sound waves through blood samples could make cancer diagnosis and treatment quicker and easier.
Researchers at the University of British Columbia created a ‘smart stent’ empowered with sensors that can monitor and provide real-time feedback on blood flow to help decrease restenosis or the narrowing of arteries.
A new device captures circulating tumor cells (CTCs) in the blood stream, providing a new avenue for early detection of metastatic cancer, as well as opportunities to test the source of the cells or the effectiveness of ongoing treatment.
Tony Kim of Georgia Tech discusses his use of microchips and nanomaterials in atherosclerosis research.
Graphene-based neural sensors are showing promise in the treatment of brain disorders and injuries.
A manufacturer would never dream of creating a new airliner or vehicle part without first going through rigorous computational modeling. Prof. Alison Marsden, Stanford University, says this is how bioengineers should think and work as well, specifically when operating on our most vital organ, the heart.
Being able to sense a change in pressure on the brain after a traumatic brain injury would allow for swifter treatment that could stave off debilitating or fatal complications.
Researchers seeking to implant a biosensor within the small intestine are developing an implantation capsule robot that can be swallowed.
A cancer research company's "No Cell Left Behind" technology can identify just five cells in a sample of 30 million.
In the era of personalized medicine, the microbiome industry’s growth trajectory parallels that of genomics in the early 2000s. According to Frost & Sullivan, the global demand for more effective medicines and healthier nutrition will continue to drive the development of microbiomic products. Here are the latest trends.
Geneticists may soon use a new type of strain sensor to sequence DNA faster and cheaper than anything they now have in their labs.